Royal Bank of Canada
PGEN icon

Royal Bank of Canada’s Precigen PGEN Stock Holding History

Royal Bank of Canada’s Portfolio PGEN Stock Details PGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$41K Buy
10,714
+5,426
+103% +$22.3K ﹤0.01% 5586
2025
Q4 		$23K Sell
5,288
-75,120
-93% -$291K ﹤0.01% 5968
2025
Q3 		$264K Sell
80,408
-295,288
-79% -$834K ﹤0.01% 4911
2025
Q2 		$533K Buy
375,696
+366,700
+4,076% +$521K ﹤0.01% 4419
2025
Q1 		$13K Sell
8,996
-9,478
-51% -$14.9K ﹤0.01% 6069
2024
Q4 		$21K Buy
18,474
+5,760
+45% +$4.91K ﹤0.01% 6092
2024
Q3 		$13K Sell
12,714
-6,052
-32% -$7.63K ﹤0.01% 6267
2024
Q2 		$30K Buy
18,766
+14,809
+374% +$21.5K ﹤0.01% 5891
2024
Q1 		$6K Sell
3,957
-36,954
-90% -$53.1K ﹤0.01% 6392
2023
Q4 		$55K Sell
40,911
-145,124
-78% -$171K ﹤0.01% 5939
2023
Q3 		$264K Buy
186,035
+171,220
+1,156% +$243K ﹤0.01% 4552
2023
Q2 		$17K Buy
14,815
+5,925
+67% +$6.99K ﹤0.01% 6289
2023
Q1 		$10K Sell
8,890
-3,106
-26% -$4.48K ﹤0.01% 6320
2022
Q4 		$18K Buy
11,996
+8,645
+258% +$14.9K ﹤0.01% 6346
2022
Q3 		$7K Buy
3,351
+364
+12% +$768 ﹤0.01% 6603
2022
Q2 		$4K Sell
2,987
-8,802
-75% -$13.1K ﹤0.01% 6750
2022
Q1 		$24K Sell
11,789
-50,284
-81% -$122K ﹤0.01% 6513
2021
Q4 		$230K Sell
62,073
-1,473
-2% -$6.34K ﹤0.01% 5199
2021
Q3 		$318K Buy
63,546
+38,535
+154% +$222K ﹤0.01% 4727
2021
Q2 		$163K Buy
25,011
+1,273
+5% +$8.89K ﹤0.01% 5246
2021
Q1 		$164K Buy
23,738
+5,046
+27% +$42.7K ﹤0.01% 5099
2020
Q4 		$190K Sell
18,692
-1,206
-6% -$7.82K ﹤0.01% 4893
2020
Q3 		$70K Buy
19,898
+612
+3% +$2.9K ﹤0.01% 5177
2020
Q2 		$96K Sell
19,286
-27,029
-58% -$92K ﹤0.01% 4869
2020
Q1 		$158K Buy
46,315
+5,127
+12% +$22.1K ﹤0.01% 4482
2019
Q4 		$226K Buy
41,188
+18,451
+81% +$104K ﹤0.01% 4560
2019
Q3 		$131K Sell
22,737
-3,522
-13% -$23.9K ﹤0.01% 4674
2019
Q2 		$202K Buy
26,259
+9,064
+53% +$48.8K ﹤0.01% 4477
2019
Q1 		$91K Buy
17,195
+4,309
+33% +$29.9K ﹤0.01% 4832
2018
Q4 		$85K Sell
12,886
-10,704
-45% -$120K ﹤0.01% 4804
2018
Q3 		$407K Sell
23,590
-3,823
-14% -$56.9K ﹤0.01% 4035
2018
Q2 		$383K Buy
27,413
+5,392
+24% +$91.1K ﹤0.01% 3992
2018
Q1 		$339K Buy
22,021
+7,117
+48% +$102K ﹤0.01% 3976
2017
Q4 		$171K Sell
14,904
-1,455
-9% -$21.7K ﹤0.01% 4514
2017
Q3 		$311K Buy
16,359
+1,337
+9% +$27.5K ﹤0.01% 4165
2017
Q2 		$362K Sell
15,022
-2,832
-16% -$62.1K ﹤0.01% 3923
2017
Q1 		$354K Sell
17,854
-11,038
-38% -$246K ﹤0.01% 3919
2016
Q4 		$695K Sell
28,892
-6,556
-18% -$182K ﹤0.01% 3460
2016
Q3 		$984K Buy
35,448
+12,483
+54% +$330K ﹤0.01% 3113
2016
Q2 		$560K Sell
22,965
-16,940
-42% -$481K ﹤0.01% 3593
2016
Q1 		$1.34M Buy
39,905
+4,604
+13% +$145K ﹤0.01% 2802
2015
Q4 		$1.05M Sell
35,301
-19,341
-35% -$652K ﹤0.01% 3061
2015
Q3 		$1.72M Buy
54,642
+34,462
+171% +$1.68M ﹤0.01% 2399
2015
Q2 		$976K Buy
20,180
+18,051
+848% +$761K ﹤0.01% 2939
2015
Q1 		$92K Buy
+2,129
New +$76.5K ﹤0.01% 4661
2013
Q4 		– Sell
-400
Closed -$9K – 6081
2013
Q3 		$9K Buy
+400
New +$9.23K ﹤0.01% 5460

Other funds holding PGEN

PCM
Patient Capital Management Baltimore, Maryland $2.74B AUM 43.59% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DC
Diametric Capital Boston, Massachusetts $385M AUM 31.7% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
OCM
Occam Crest Management Darien, Connecticut $165M AUM
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return

Royal Bank of Canada's PGEN Position: Q1 2026 in Review

Royal Bank of Canada increased its Precigen (PGEN) stake by 103% in Q1 2026, buying an estimated $22.3K and bringing the position to 10,714 shares worth $41K. The position accounts for ﹤0.01% of the portfolio, ranked #5586.

Royal Bank of Canada first reported a position in PGEN in Q3 2013 and has held it in 46 quarters since. The position peaked at $1.72M in Q3 2015. 206 funds tracked by Wall St. Rank hold PGEN as of Q1 2026.

  • Royal Bank of Canada held 10,714 shares of Precigen worth $41K as of Q1 2026.
  • Royal Bank of Canada bought 5,426 Precigen shares in Q1 2026, an estimated $22.3K.
  • Precigen made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #5586 holding.
  • Royal Bank of Canada first reported a position in Precigen in Q3 2013 and has held it in 46 quarters since.
  • Royal Bank of Canada's Precigen position peaked at $1.72M in Q3 2015.
  • 206 funds tracked by Wall St. Rank held Precigen as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.